Previous 10 | Next 10 |
The following slide deck was published by Lantheus Holdings, Inc. in conjunction with this event. For further details see: Lantheus (LNTH) Investor Presentation - Slideshow
NORTH BILLERICA, Mass, March 03, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), an established leader and fully integrated provider committed to innovative imaging diagnostics, targeted therapeutics, and artificial intelligence solutions to fi...
The following slide deck was published by Lantheus Holdings, Inc. in conjunction with their 2021 Q4 earnings call. For further details see: Lantheus Holdings, Inc. 2021 Q4 - Results - Earnings Call Presentation
Gainers: Aerie Pharmaceuticals (NASDAQ:AERI) +25%. Schrodinger (NASDAQ:SDGR) +17%. MDxHealth (NASDAQ:MDXH) +16%. Lantheus (NASDAQ:LNTH) +13%. Tabula Rasa HealthCare (NASDAQ:TRHC) +13%. Losers: Baudax Bio BXRX -55%. The Joint (NASDAQ:JYNT) -15%. Biohaven...
Russia's invasion of Ukraine triggered a volatile session on Wall Street, with the major averages recovering from an early selling spree to finish Thursday's trading with gains. With tech stocks leading both the initial selling and the late recovery, the Nasdaq went full circle, turning an ea...
Lantheus Holdings (NASDAQ: LNTH) had one of the best days of its life on the stock exchange Thursday. The specialty healthcare company saw its shares blast more than 39% higher on the strength of its latest earnings report, published that morning. For its Q4 of 2021, Lantheus ea...
Gainers: Indonesia Energy Corporation (NYSE:INDO) +65%. Camber Energy (NYSE:CEI) +40%. South Jersey Industries (NYSE:SJI) +40%. Post Holdings (NYSE:POST) +34%. Lantheus Holdings (NASDAQ:LNTH) +33%. Imperial Petroleum (NASDAQ:IMPP) +30%. Cyren (NASDAQ:CYRN) +28%. TransMedics Group (NASDAQ:TMDX...
Lantheus Holdings, Inc. (LNTH) Q4 2021 Earnings Conference Call February 24, 2022, 8:00 AM ET Company Participants Mary Anne Heino – President and Chief Executive Officer Mark Kinarney – Senior Director of Investor Relations Paul Blanchfield – Chief Commercial Officer Rob...
Gainers: Lantheus (NASDAQ:LNTH) +34%. Evolent Health (NYSE:EVH) +18%. Clover Health (NASDAQ:CLOV) +10%. Liquidia (NASDAQ:LQDA) +10%. iRhythm Technologies (NASDAQ:IRTC) +8%. Losers: Orphazyme (NASDAQ:ORPH) -36%. Rhythm Pharmaceuticals (NASDAQ:RYTM) -24%. Tabu...
Healthcare supplier Lantheus Holdings (NASDAQ:LNTH) has added ~32% in the pre-market Thursday on above-average volume after the company set its outlook ahead of Wall Street forecasts on the back of a strong beat in its Q4 2021 financials. Worldwide revenue for the quarter and f...
News, Short Squeeze, Breakout and More Instantly...
Lantheus Holdings Inc. Company Name:
LNTH Stock Symbol:
NASDAQ Market:
Lantheus Holdings Inc. Website:
2024-08-01 08:00:12 ET David Turkaly from JMP Securities issued a price target of $125.00 for LNTH on 2024-08-01 07:13:00. The adjusted price target was set to $125.00. At the time of the announcement, LNTH was trading at $104.83. The overall price target consensus is at...
Second Quarter 2024 Worldwide revenue of $394.1 million, an increase of 22.5% from second quarter 2023 Completed three strategic transactions to expand innovative pipeline GAAP fully diluted earnings per share of $0.88, compared to $1.33 in second quarter 2023. Adjusted fully ...
BEDFORD, Mass., July 17, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Wednesday, July 31, 2024, to discuss its financial and operating results for the second...